AgeX Therapeutics is a US-based biotechnology company that develops innovative treatments for aging and degenerative conditions like obesity and heart disease. Their lead cell and drug-based therapies include AGEX-BAT1 for age-related metabolic disorders, AGEX-VASC1 for aged ischemic tissues, AGEX-iTR1547 for scarless wound repair, and AGEX-iTR1550 for induced tissue regeneration. In collaboration with the University of California at Irvine, they conduct research for treating neurological disorders using cellular therapy.